Related Experiment Video
Updated: Jan 24, 2026
09:32
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
Published on: January 20, 2023
4.0K
Challenges in IBD Research: Pragmatic Clinical Research
Frank I Scott1, David T Rubin2, Subra Kugathasan3
1Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO, USA.
Inflammatory Bowel Diseases
|May 17, 2019
Summary
This research addresses critical gaps in inflammatory bowel diseases (IBD) research, focusing on pragmatic clinical studies to improve patient care. It emphasizes real-world evidence and diverse cohorts to optimize IBD treatment and management strategies.
Area of Science:
- Gastroenterology and Clinical Research
- Inflammatory Bowel Diseases (IBD) Research
Background:
- The Challenges in IBD research document identifies key research gaps and proposes actionable strategies.
- Pragmatic clinical research is a crucial focus area for optimizing and standardizing IBD care.
Purpose of the Study:
- To highlight critical gaps in pragmatic clinical research for inflammatory bowel diseases (IBD).
- To propose actionable approaches for addressing these gaps and advancing IBD care.
Main Methods:
- Leveraging emerging data sources and real-world evidence (RWE) for epidemiologic and therapeutic trend analysis.
- Conducting epidemiological studies in diverse cohorts to assess IBD incidence, prevalence, and treatment outcomes.
- Implementing novel clinical trial designs to evaluate medication positioning, therapeutic drug monitoring (TDM), and pain management.
Main Results:
- Identified key research gaps: IBD incidence/prevalence, medication positioning, TDM utility, pain management, and healthcare economics.
- Emphasized the need for RWE to understand epidemiologic and therapeutic trends in IBD.
- Proposed diverse cohort studies and new clinical trial methodologies for improved IBD care.
Conclusions:
- Addressing identified gaps requires a focus on pragmatic clinical research, RWE, and diverse populations.
- Standardizing IBD care necessitates understanding incidence, prevalence, optimal treatments, and resource utilization.
- Multidisciplinary approaches and innovative trial designs are essential for advancing IBD management and patient outcomes.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
482
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
482
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
454
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
454
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
512
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
512
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
521
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
521
01:27Nursing Clinical Information System
1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
01:16Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K